LC-MS/MS in the Clinical Laboratory. Jo Adaway

Similar documents
Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Quantitative analysis of small molecules in biological samples. Jeevan Prasain, Ph.D. Department of Pharmacology & Toxicology, UAB.

Presentation Basic Introduction to Instrumentation Matrix Effects Challenges

HPLC Winter Webinars Part 2: Sample Preparation for HPLC

Plasma Metanephrines and 3-Methoxytyramine by LC/MS/MS Using Agilent SimpliQ WCX SPE, 1290 Infi nity LC, and 6460 Triple Quadrupole LC/MS

Strategies for the Analysis of Therapeutic Peptides in Biofluids by LC-MS/MS. Lee Goodwin

TR ACE ORGANIC. lgcstandards.com/foodandenvironment

Extraction of Methylmalonic Acid from Serum Using ISOLUTE. SAX Prior to LC-MS/MS Analysis

Improved Extraction of THC and its Metabolites from Oral Fluid Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18

CLSI C60: Method Development

Analytical determination of testosterone in human serum using an Agilent Ultivo Triple Quadrupole LC/MS

OUTLINE 18/08/2011 NEW DEVELOPMENTS IN LC/MS/MS FRONT-END AUTOMATION. Expanding role of tandem mass spectrometry in the clinical laboratory

Plasma-free Metanephrines Quantitation with Automated Online Sample Preparation and a Liquid Chromatography-Tandem Mass Spectrometry Method

High-Throughput LC-MS/MS Quantification of Estrone (E1) and Estradiol (E2) in Human Blood Plasma/Serum for Clinical Research Purposes

Chemical derivatization

Contact Information. Speaker Financial Disclosure Information. Fitting Linear Quadrupoles and Round Flight Tubes into the Square Clinical Laboratory

isobaric Barbiturates in Serum using LDTD- MS/MS combined with differential mobility

Chromatography. Gas Chromatography

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

[ APPLICATION NOTEBOOK ] MASS SPECTROMETRY APPLICATION SOLUTIONS FOR ENDOCRINOLOGY RESEARCH

Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA USA APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Fast and Reliable Method for the Analysis of Methylmalonic Acid from Human Plasma

Rapid Screening and Confirmation of Melamine Residues in Milk and Its Products by Liquid Chromatography Tandem Mass Spectrometry

Cisbio Bioassays Parc Marcel Boiteux BP Codolet / France

Development of analytical methods for Catecholamines, Metanephrines and related metabolites in urine and plasma matrices

Chromatography & instrumentation in Organic Chemistry

Study of Non-Covalent Complexes by ESI-MS. By Quinn Tays

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

TANDEM MASS SPECTROSCOPY

Chapter content. Reference

Toxicity, Teratogenic and Estrogenic Effects of Bisphenol A and its Alternative. Replacements Bisphenol S, Bisphenol F and Bisphenol AF in Zebrafish.

COLA Mass Spec Criteria

Appendix II- Bioanalytical Method Development and Validation

Definitive EtG/EtS LC-MS/MS Analysis:

Improved Automated Sample Preparation for the Analysis of 25-OH-Vitamin D3 by LC/MS/MS

Quality control analytical methods- Switch from HPLC to UPLC

Ultrafast Analysis of Buprenorphine and Norbuprenorphine in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System

Quantification of growth promoters olaquindox and carbadox in animal feedstuff with the Agilent 1260 Infinity Binary LC system with UV detection

VMA, HVA, 5-HIAA Urine LC-MS/MS Analysis Kit User Manual

Clinical Toxicology. Biomass Component Extraction: The uneaten cooked plant specimen was prepared for

Tecan AC Extraction Plate

Utilizing ELSD and MS as Secondary Detectors for Prep HPLC and Flash Chromatography. Tips and Techniques to Optimize ELSD and MS based Purification

Analysis of Synthetic Cannabinoids and Metabolites: Adding New Compounds to an Existing LC-MS/MS Method

CHAPTER CHROMATOGRAPHIC METHODS OF SEPARATIONS

Introduction to LC-MS

Figure 1. The supported liquid extraction process using the ISOLUTE SLE plate (single well shown)

Assay Robustness Improvement for Drug Urinalysis Using FAIMS and H-SRM on a Triple- Quadrupole Mass Spectrometer

January March JCPS Volume 6 Issue 1.

AB SCIEX SelexION Technology Used to Improve Mass Spectral Library Searching Scores by Removal of Isobaric Interferences

Quantitation of a target protein in crude samples using targeted peptide quantification by Mass Spectrometry

Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC-MS/MS for Forensic Toxicology

A High Sensitivity Dual Solid Phase Extraction LC-MS/MS Assay for the Determination of the Therapeutic Peptide Desmopressin in Human Plasma

2010 Waters Corporation. Xevo TQ-S for Bioanalysis

Chemistry Instrumental Analysis Lecture 28. Chem 4631

Quantitation of Ethyl Glucuronide and Ethyl Sulfate in Urine using LC-MS/MS

CHROMATOGRAPHY. The term "chromatography" is derived from the original use of this method for separating yellow and green plant pigments.

LC-MS/MS Method for the Determination of Diclofenac in Human Plasma

Analysis of Illegal Dyes in Food Matrices using Automated Online Sample Preparation with LC/MS

Psychoactive Drugs Urine LC-MS/MS Analysis Kit User Manual

High Performance Liquid Chromatography

A Sensitive and Reproducible Signature Peptide MRM Based Quantitation Method for Pegylated Interferon α-2b in Serum

TITLE: Estimation of Drugs in Biological Fluids by Liquid Chromatography Tandem Mass Spectrometry 1.1 THE OUTLOOK 02 1.

LC/MS/MS qua ntitation of β-estradiol 17-acetate using an Agilent 6460 Triple Quadrupole LC/MS working in ESI negative ion mode

Introduction. Abstract. Barbara Maier * and Michael Vogeser

Tips & Tricks GPC/SEC: Quantify and Get More Than Molar Mass Averages

CHEMISTRY Unit 3, Area of Study 1: Chemical Analysis

INTRODUCTION OVERVIEW

Option D: Medicinal Chemistry

Chromatography. Mrs. D. MEENA MPharm PA & QA KTPC

Methods Development Process for Bioanalysis" Stuart Coleman March 22, 2007

Potential sources of contamination on Mass Spectrometers and suggested cleaning procedures

camp Direct Immunoassay Kit

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

Isotope Dilution Mass Spectrometry

Patient samples Use of patient samples was according to approved guidelines of the University of Washington Human Subjects Division.

1 INTENDED USE Competitive immunoenzymatic colorimetric method for the quantitative determination of DHEA-S concentration in saliva.

25-OH VITAMIN D 3 AND 25-OH VITAMIN D 2 IN PLASMA BY UV / VIS FAST CODE Z19710

Development and application of methodology for designer drugs

CHROMATOGRAPHY AND MASS SPECTROMETER

A Pre-Clinical Pharmacokinetic-Pharmacodynamic Modelling and Biodistribution Studies of Donepezil Hydrochloride by Validated HPLC Method

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

Quantitation of High Resolution MS Data Using UNIFI: Acquiring and Processing Full Scan or Tof-MRM (Targeted HRMS) Datasets for Quantitative Assays

Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry

CHAPTER 1 Role of Bioanalytical Methods in Drug Discovery and Development

CHAPTER 6 GAS CHROMATOGRAPHY

Liquid Chromatography

Mixed-Mode, Weak Anion-Exchange, Solid-Phase Extraction Method for the Extraction of Niflumic Acid from Human Plasma

Macrolides in Honey Using Agilent Bond Elut Plexa SPE, Poroshell 120, and LC/MS/MS

TargetScreener. Innovation with Integrity. A Comprehensive Screening Solution for Forensic Toxicology UHR-TOF MS

2501 High Performance Liquid Chromatography

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

Zinc-Protoporphyrin/ Protoporphyrin HPLC Kit

Perfluorinated Alkyl Acids (PFAA) in Water by LC/MS/MS - PBM

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

Supporting information Online HPLC-ESI-HRMS Method for the Analysis and Comparison of Different Dissolved Organic Matter Samples

Selecting and planning for the right mass spectrometer

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

Simultaneous analysis for forensic drugs in human blood and urine using ultra-high speed LC-MS/MS

[application note] INTRODUCTION EXPERIMENTAL. Specimens. Extraction

Transcription:

LC-MS/MS in the Clinical Laboratory Jo Adaway

LC-MS/MS in the clinical laboratory LC-MS/MS is mainly used for quantification of analytes used in the diagnosis and monitoring of disease Semi-quantitative assays are used for e.g. drugs of abuse analysis Screening for unknown compounds e.g. legal highs MALDI-ToF fingerprinting in microbiology.

Clinical Biochemistry at UHSM Serve population of 570,000 2,160000 tests per year Main bulk of work carried out on automated analysers

LC-MS/MS at UHSM 6 mass spectrometers 1 x Waters Quattro Premier

LC-MS/MS at UHSM 6 mass spectrometers 2 x Xevo TQD

LC-MS/MS at UHSM 6 mass spectrometers 1 x Xevo TQ-MS

LC-MS/MS at UHSM 6 mass spectrometers 2 x Xevo TQ-S with Online Sample Manager

LC-MS/MS at UHSM 25 routine analyses by LC-MS/MS Therapeutic drug monitoring Immunosuppressants Antifungal Prednisolone Tumour markers Metanephrines 5-HIAA Steroids Cortisol Aldosterone and renin Androgens Urine tests Urine stone screens cotinine

Steroids (MRM) Vitamin D Cortisol (serum, urine & saliva) Testosterone (serum & saliva) Androstenedione DHEAS 17-hydroxyprogesterone 11-deoxycortisol Cortisone Aldosterone Oestradiol Progesterone.etc Synthetics e.g. prednisolone etc

Other clinical Uses Paediatrics Drugs of abuse/toxicology Haemoglobin

Ion suppression Ion suppression is a matrix effect that causes a decrease in ionisation of the analyte of interest. This can vary between patient samples, so it is important to identify ion suppression in an assay, to remove it if possible or to compensate for it.

Causes of ion suppression Co-elution with analyte of interest of: Non-volatile components e.g. salts Endogenous compounds e.g. peptides, amino acids, phospholipids Plasticisers Drugs/metabolites Drug delivery vehicles e.g. PEG Ion pair reagents

Causes of ion suppression In general: Molecules of higher mass tend to suppress ionisation of those of lower mass More polar analytes are susceptible to suppression

Mechanism of ion suppression in ESI No-one really knows! Theories include: Competition for charge between analyte and suppressor Large concentrations of non-volatile agents affecting the surface tension of the droplet & affecting evaporation efficiency

Detection of ion suppression Post column infusion of compound into MS whilst injecting extracted sample via HPLC. If endogenous analyte, may need to infuse stable isotope of analyte instead It is important to carry out ion suppression experiments using plasma from different sources AND collected in all the types of tubes you are likely to encounter.

Detection of ion suppression

Detection of ion suppression

Quantification of ion suppression Prepare 3 types of standard curves using 5-6 lots of plasma from different sources: 1 in mobile phase baseline recovery Also gives an idea of system reproducibility 1 in plasma which has been spiked post extraction This shows any matrix effects 1 in plasma spiked pre-extraction Adds in the effects of extraction efficiency Matuszewski et al, Anal. Chem. 2003: 75; 3019

Quantification of ion suppression Ideally, all 3 curves should overlay: 70 Peak area 60 50 40 30 20 10 Solvent spike Spike preextraction Spike postextraction 0 1 2 3 4 5 6 7 Concentration

Quantification of ion suppression In real life, this may not occur. To calculate ion suppression due to matrix effects: (Peak area of analyte spiked after extraction/peak area of analyte spiked into mobile phase) x 100 <100% = ion suppression >100% = ion enhancement

Quantification of ion suppression To calculate the extraction efficiency: (Peak area of analyte spiked before extraction/peak area of analyte spiked after extraction) x 100 To calculate the efficiency of the whole process: Matrix effect (%) x extraction efficiency (%)/100

Quantification of ion suppression Mean peak area in mobile phase = 10000 Mean peak area spiked pre-extraction = 7500 Mean peak area spiked post-extraction = 9000 Matrix effect = 9000/10000 x 100 = 90% Extraction efficiency = 7500/9000 x 100 = 83% Process efficiency = 90 x 83 / 100 = 75%

Quantification of ion suppression +/- 10% is probably acceptable. Ion suppression/enhancement greater than this may require changes in the method.

Internal standards The same amount of internal standard is added to each standard, sample and QC. Using the response of sample/internal standard compensates for changes in sample extraction, ionisation efficiency and some ion suppression.

Internal standards Ideally we use a stable isotope labelled version of the analyte of interest. 13 C or 15 N versions are best as there is a greater difference in physico-chemical properties between H isotopes than the others due to the greater size difference 2 H binds more strongly to carbon than 1 H which may introduce small differences in chromatographic separation between analytes and deuterium labelled internal standards, especially if UPLC is used, reducing their ability to compensate for ion suppression effects

Stable isotope internal standards Berg & Helge Strand J Chrom. A 2011: 1218; 9366-9374

Sample preparation The method of sample preparation is very important Choice of sample prep can depend on: Sample type Concentration of analyte of interest Interfering substances Ion suppression Equipment availability

Sample dilution Simplest method of sample preparation Most suited to aqueous samples where matrix effects won t be an issue Can be used for urine samples or saliva, but ion suppression may be a problem Examples urine 5-HIAA

Protein precipitation Zinc sulphate is used to precipitate large proteins such as immunoglobulins. In a whole blood assay, it also lyses the cells to release the contents. Acetonitrile or methanol is then added to precipitate smaller proteins and also zinc sulphate. Samples are centrifuged before analysis and only the supernatant is injected. Examples of this include cyclosporin and tacrolimus, sirolimus and everolimus, MPA and voriconazole.

Liquid liquid extraction Separates compounds based on their relative solubilities in two immiscible liquids. Solvents commonly used include hexane, DCM and MTBE Solvent is added to sample plus internal standard, then mixed to extract. The solvent layer is separated from the matrix, and can be dried down to add a concentration step.

Liquid liquid extraction Organic solvent Sample Mix Separate

Liquid liquid extraction

Liquid liquid extraction

Supported liquid extraction Uses modified diatomaceous earth as a solid support for liquid liquid extraction. Sample is diluted with water and internal standard, then applied to the support. After adsorption onto the diatomaceous earth, the analyte is eluted, then the solvent evaporated and sample reconstituted.

Supported liquid extraction

Solid phase extraction This uses the affinity of solutes dissolved in the liquid mobile phase for the stationary solid phase

Solid phase extraction Condition Equilibrate Load sample Wash Elute

Solid phase extraction

Solid phase extraction

Solid phase extraction

Solid phase extraction

Solid phase extraction

Solid phase extraction

Isobaric interferences Isobaric refers to another molecule with the same mass These may also fragment to give same daughter ions

Isobaric interferences 21 deoxycortisol, 11 deoxycortisol & corticosterone 21 deoxycortisol 11 deoxycortisol corticosterone

Isobaric interferences Natural isotope of any carbon containing compound M + 1, M + 2 M + 2 will have same m/z as doubly deuterated internal standard

Isobaric interferences Duxbury et al, Ann Clin Biochem 2008

Isobaric interferences Response 90 80 70 60 50 40 30 20 10 0 0 500 1000 1500 Cortisol (nmol/l) 15 ug/l d2- cortisol 3.75 ug/l d2-cortisol 1.5 ug/l d2- cortisol 6 5 R 2= 0.9954 Response 4 3 2 1 0 0 500 1000 1500 2000 Cortisol (nmol/l)

Isobaric interferences Reported M+2 effect of prednisolone in cortisol assays Cortisol Mr = 362 Prednisolone Mr = 360

Isobaric interferences Chromatography required to separate isobaric interference Can be difficult due similar structure Particular problem for steroids Structural isomers M+2 isotopes

Quantifier and qualifier transitions Two transitions tuned per compound Most sensitive transition used for quantification Secondary transition used for qualification Ion ratios monitored Should remain constant Difference in ion ratio suggests interference

Calibrators Some kits aimed at LC-MS/MS available Often include columns, precipitation reagent and internal standards (and calibrators) Most assays use calibrators prepared in house Can be the source of wide inter-laboratory differences Anchor to reference material or comparison with reference laboratory Often not possible or very expensive Comparison with established LC-MS/MS assays

Calibrator matrix Serum/plasma Simple for drug assays Difficult for e.g. steroid assays Animal serum e.g. horse Not the same as human matrix Charcoal stripped serum/plasma Adulterated Aqueous based e.g. PBS based Only if no matrix effects in assay

Conclusion The main use of mass spectrometry in clinical labs is for quantification of analytes Internal standards are used to compensate for ion suppression and for changes in extraction and ionisation efficiency Many different sample preparation techniques are available, and the choice of technique depends on analyte concentration, ion suppression, interfering analytes and equipment availability Automation is making sample preparation much faster and more robust. There are many different things to take into account when developing an assay, such as isobaric interferences, choice of calibrator and the plastics used in sample preparation.